Tetanus- a case report highlighting the challenges in diagnosis and treatment.
clostridium tetani
Tetanus
Treatment
Vaccination
Journal
Tropical diseases, travel medicine and vaccines
ISSN: 2055-0936
Titre abrégé: Trop Dis Travel Med Vaccines
Pays: England
ID NLM: 101674442
Informations de publication
Date de publication:
01 Jun 2024
01 Jun 2024
Historique:
received:
31
12
2023
accepted:
14
03
2024
medline:
1
6
2024
pubmed:
1
6
2024
entrez:
1
6
2024
Statut:
epublish
Résumé
Tetanus has become an increasingly rare infectious disease due to the development of successful vaccination programs in the mid-20th century. In resource-rich countries, mainly unvaccinated or partly vaccinated risk groups are affected, whereas tetanus still remains prevalent in resource-limited countries. The decreasing incidence in developed countries has hindered clinical trials evaluating the best treatment modalities for tetanus infections. Current guidelines are based on a small number of studies and case reports. So far, these studies have shown potential benefits of treating tetanus infections with benzodiazepines, magnesium sulfate and baclofen. Additionally, several treatments have been shown to be useful in stabilizing and supporting patients with tetanus. However, each treatment modality has limitations, from negative side effects to logistical challenges, especially in developing countries. Therefore, further knowledge is required to evaluate the best use of each treatment and to further optimize patient care. This knowledge can contribute to the reduction of the burden of disease in countries where tetanus remains prevalent and where resources are limited, though vaccination is the most effective method to achieve this. This case report describes the treatment of a Dutch patient with tetanus infection and illustrates the role of benzodiazepines as well as other key aspects of treating patients with tetanus.
Identifiants
pubmed: 38822438
doi: 10.1186/s40794-024-00220-5
pii: 10.1186/s40794-024-00220-5
doi:
Types de publication
Journal Article
Langues
eng
Pagination
10Informations de copyright
© 2024. The Author(s).
Références
Tetanus vaccines. WHO position paper– February 2017. Wkly Epidemiol Rec. 2017;92(6):53–76.
Tetanus. https://www.who.int/news-room/fact-sheets/detail/tetanus : World Health Organization; 2023 [updated 24 August 2023].
Thwaites L, Tetanus. https://www.uptodate.com/contents/tetanus 2023 [updated 10 June 2022].
Li J, Liu Z, Yu C, Tan K, Gui S, Zhang S, Shen Y. Global epidemiology and burden of tetanus from 1990 to 2019: a systematic analysis for the global burden of Disease Study 2019. Int J Infect Dis. 2023;132:118–26.
doi: 10.1016/j.ijid.2023.04.402
pubmed: 37086867
Tetanus Annual Epidemiological Report. 2021. https://www.ecdc.europa.eu/sites/default/files/documents/AER%20Tetanus%202021.pdf : ECDC 2023 17-12-2023.
Behrens HOS, Dadonaite B, Roser M. Tetanus https://ourworldindata.org/tetanus 2019 [updated 25 March 2019].
RIVM, Tetanus. https://www.rivm.nl/tetanus : Rijksinstituut voor Volksgezondheid en Milieu; 2022 [updated 17 February 2022].
Chrdle A, BalejovÁ M. [Tetanus still current]. Acta Chir Orthop Traumatol Cech. 2020;87(4):292–6.
doi: 10.55095/achot2020/044
pubmed: 32940226
Schauer U, Stemberg F, Rieger CH, Büttner W, Borte M, Schubert S, et al. Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults. Clin Diagn Lab Immunol. 2003;10(2):202–7.
pubmed: 12626443
pmcid: 150524
Rodrigo C, Fernando D, Rajapakse S. Pharmacological management of tetanus: an evidence-based review. Crit Care. 2014;18(2):217.
doi: 10.1186/cc13797
pubmed: 25029486
pmcid: 4057067
Campbell JI, Lam TM, Huynh TL, To SD, Tran TT, Nguyen VM, et al. Microbiologic characterization and antimicrobial susceptibility of Clostridium tetani isolated from wounds of patients with clinically diagnosed tetanus. Am J Trop Med Hyg. 2009;80(5):827–31.
doi: 10.4269/ajtmh.2009.80.827
pubmed: 19407132
Van Hao N, Loan HT, Yen LM, Kestelyn E, Hong DD, Thuy DB, et al. Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial. Lancet Glob Health. 2022;10(6):e862–72.
doi: 10.1016/S2214-109X(22)00117-6
pubmed: 35561721
pmcid: 9115864
Thwaites CL, Loan HT. Eradication of tetanus. Br Med Bull. 2015;116(1):69–77.
pubmed: 26598719
pmcid: 4674006
Sun KO, Chan YW, Cheung RT, So PC, Yu YL, Li PC. Management of tetanus: a review of 18 cases. J R Soc Med. 1994;87(3):135–7.
doi: 10.1177/014107689408700306
pubmed: 8158589
pmcid: 1294391
Miranda-Filho Dde B, Ximenes RA, Barone AA, Vaz VL, Vieira AG, Albuquerque VM. Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route. BMJ. 2004;328(7440):615.
doi: 10.1136/bmj.38027.560347.7C
pubmed: 15003976
Geeta MG, Krishnakumar P, Mathews L. Intrathecal tetanus immunoglobulins in the management of tetanus. Indian J Pediatr. 2007;74(1):43–5.
doi: 10.1007/s12098-007-0025-y
pubmed: 17264452
Abrutyn E, Berlin JA. Intrathecal therapy in tetanus. A meta-analysis. JAMA. 1991;266(16):2262–7.
doi: 10.1001/jama.1991.03470160094039
pubmed: 1833565
Kabura L, Ilibagiza D, Menten J, Van den Ende J. Intrathecal vs. intramuscular administration of human antitetanus immunoglobulin or equine tetanus antitoxin in the treatment of tetanus: a meta-analysis. Trop Med Int Health. 2006;11(7):1075–81.
doi: 10.1111/j.1365-3156.2006.01659.x
pubmed: 16827708
Ahmadsyah I, Salim A. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. Br Med J (Clin Res Ed). 1985;291(6496):648–50.
doi: 10.1136/bmj.291.6496.648
pubmed: 3928066
Ganesh Kumar AV, Kothari VM, Krishnan A, Karnad DR. Benzathine penicillin, metronidazole and benzyl penicillin in the treatment of tetanus: a randomized, controlled trial. Ann Trop Med Parasitol. 2004;98(1):59–63.
doi: 10.1179/000349804225003037
pubmed: 15000732
Rhinesmith E, Fu L. Tetanus Disease, Treatment, Management. Pediatr Rev. 2018;39(8):430–2.
doi: 10.1542/pir.2017-0238
pubmed: 30068747
Yen LM, Thwaites CL. Tetanus Lancet. 2019;393(10181):1657–68.
doi: 10.1016/S0140-6736(18)33131-3
pubmed: 30935736
James MF, Manson ED. The use of magnesium sulphate infusions in the management of very severe tetanus. Intensive Care Med. 1985;11(1):5–12.
doi: 10.1007/BF00256058
pubmed: 3968303
Thwaites CL, Yen LM, Loan HT, Thuy TT, Thwaites GE, Stepniewska K, et al. Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial. Lancet. 2006;368(9545):1436–43.
doi: 10.1016/S0140-6736(06)69444-0
pubmed: 17055945
Rodrigo C, Samarakoon L, Fernando SD, Rajapakse S. A meta-analysis of magnesium for tetanus. Anaesthesia. 2012;67(12):1370–4.
doi: 10.1111/anae.12020
pubmed: 23033859
Müller H, Börner U, Zierski J, Hempelmann G. Intrathecal baclofen for treatment of tetanus-induced spasticity. Anesthesiology. 1987;66(1):76–9.
doi: 10.1097/00000542-198701000-00016
pubmed: 3800040
Pellanda A, Caldiroli D, Vaghi GM, Bonelli S. Treatment of severe tetanus by intrathecal infusion of baclofen. Intensive Care Med. 1993;19(1):59.
doi: 10.1007/BF01709281
pubmed: 8440802
Boots RJ, Lipman J, O’Callaghan J, Scott P, Fraser J. The treatment of tetanus with intrathecal baclofen. Anaesth Intensive Care. 2000;28(4):438–42.
doi: 10.1177/0310057X0002800415
pubmed: 10969374
Saissy JM, Raux O, Gohard R, Diatta B. [Severe tetanus and intrathecal baclofen]. Ann Fr Anesth Reanim. 1990;9(2):183–4.
doi: 10.1016/S0750-7658(05)80058-9
pubmed: 2363551
Cabrerizo García JL, Homs Gimeno CA, Pacheco Arancibia G, Zalba Etayo B. Sánchez Marteles M. [Treatment of tetanus with intrathecal baclofen]. Med Interna. 2008;25(7):372–3.
Engrand N, Vilain G, Rouamba A, Benhamou D. [Value of intrathecal baclofen in the treatment of severe tetanus in the tropical milieu]. Med Trop (Mars). 2000;60(4):385–8.
pubmed: 11436597
François B, Clavel M, Desachy A, Vignon P, Salle JY, Gastinne H. [Continuous intrathecal injection of baclofen in generalized tetanus. A therapeutic alternative]. Presse Med. 1997;26(22):1045–7.
pubmed: 9246113
Saissy JM, Demazière J, Vitris M, Seck M, Marcoux L, Gaye M, Ndiaye M. Treatment of severe tetanus by intrathecal injections of baclofen without artificial ventilation. Intensive Care Med. 1992;18(4):241–4.
doi: 10.1007/BF01709840
pubmed: 1430590
Vitris M, Saissy JM, Demaziere J, Seck M, Ndiaye M, Gaye N, Marcoux L. [Treatment of severe tetanus by repeated intrathecal injections of baclofen]. Dakar Med. 1991;36(1):28–9.
pubmed: 1842757
Solsona M, Miró G, Yébenes JC, Balanzó X, Almirall J, Mauri M. [Tetanus treated with continuous baclofen intrathecal perfusion]. Med Intensiva. 2007;31(4):204–6.
doi: 10.1016/S0210-5691(07)74807-6
pubmed: 17562306
Dressnandt J, Konstanzer A, Weinzierl FX, Pfab R, Klingelhöfer J. Intrathecal baclofen in tetanus: four cases and a review of reported cases. Intensive Care Med. 1997;23(8):896–902.
doi: 10.1007/s001340050429
pubmed: 9310810
Dundee JW, Morrow WF. Labetalol in severe tetanus. Br Med J. 1979;1(6171):1121–2.
doi: 10.1136/bmj.1.6171.1121
pubmed: 444960
pmcid: 1598717
Domenighetti GM, Savary G, Stricker H. Hyperadrenergic syndrome in severe tetanus: extreme rise in catecholamines responsive to labetalol. Br Med J (Clin Res Ed). 1984;288(6429):1483–4.
doi: 10.1136/bmj.288.6429.1483
pubmed: 6426611
Hanna W, Grell GA. Oral labetalol in the management of the sympathetic overactivity of severe tetanus. South Med J. 1980;73(5):653–4.
doi: 10.1097/00007611-198005000-00030
pubmed: 6103586
Gregorakos L, Kerezoudi E, Dimopoulos G, Thomaides T. Management of blood pressure instability in severe tetanus: the use of clonidine. Intensive Care Med. 1997;23(8):893–5.
doi: 10.1007/s001340050428
pubmed: 9310809
Rocke DA, Wesley AG, Pather M, Calver AD, Hariparsad D. Morphine in tetanus–the management of sympathetic nervous system overactivity. S Afr Med J. 1986;70(11):666–8.
pubmed: 3787380
Hibberd PL. Tetanus-diphtheria toxoid vaccination in adults https://www.uptodate.com/contents/tetanus-diphtheria-toxoid-vaccination-in-adults#:~:text=Routine%20adult%20immunization%20%E2%80%94%20In%20the,immunization%20against%20tetanus%20and%20diphtheria 2023 [updated 07 June 2023].
Landelijke Coördinatie Infectieziektebestrijding. https://lci.rivm.nl/richtlijnen/tetanus Rijksinstituut voor Volksgezondheid en Milieu (RIVM); [updated 23 December 2022].
Millward G. Vaccinating Britain: Mass vaccination and the public since the Second World War. Manchester University; 2019.
Oiseth SJL, Maza E, Tetanus. Concise medical knowledge [cited 2023 Dec 17]. Available from: https://www.lecturio.com/concepts/tetanus/ .
Yeh FL, Dong M, Yao J, Tepp WH, Lin G, Johnson EA, Chapman ER. SV2 mediates entry of tetanus neurotoxin into central neurons. PLoS Pathog. 2010;6(11):e1001207.
doi: 10.1371/journal.ppat.1001207
pubmed: 21124874
pmcid: 2991259